Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 02, 2015 3:57 AM ET

Life Sciences Tools and Services

Company Overview of Furiex Pharmaceuticals, Inc.

Executive Profile

June S. Almenoff M.D., Ph.D., F.A.C.P.

President, Chief Medical Officer and Director, Furiex Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. June S. Almenoff, M.D., Ph.D. is an Executive-in-Residence at Hatteras Venture Partners. Dr. Almenoff is a Consulting Professor of Medicine at Duke University Medical Center and was previously a Faculty. She was the Chief Medical Officer, Principal Executive Officer, Member of the Board of Directors, and President of Furiex Pharmaceuticals, Inc. since March 16, 2010 and a Director since May 2012. At Furiex Pharmaceuticals, Inc., she served as most senior executive ...

Corporate Headquarters

3900 Paramount Parkway
Morrisville, North Carolina 27560

United States

Phone: 919-456-7800
Fax: --

Board Members Memberships

President, Chief Medical Officer and Director
Independent Director, Member of Compensation Committee and Member of Audit Committee


Smith College
Mount Sinai School Of Medicine
Mount Sinai School Of Medicine

Other Affiliations

Annual Compensation

Total Annual Compensation$379,455

Stocks Options

Restricted Stock Awards$625,680
All Other Compensation$30,395
Exercisable Options$225,113
Exercisable Options Value$6,927,292
Unexercisable Options$28,882
Unexercisable Options Value$801,174
Total Value of Options$7,728,466
Total Number of Options$253,995

Total Compensation

Total Annual Cash Compensation$534,850
Total Short Term Compensation$379,455
Other Long Term Compensation$656,075
Total Calculated Compensation$1,160,530

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Furiex Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at